In the Journal of Antimicrobial Chemotherapy Stein Schalkwijk, Rob ter Heine, Angela Colbers and David Burger investigated how pregnant women should be treated with the anti-HIV drug darunavir.Darunavir is pharmacotherapeutic cornerstone in treatment of HIV. During pregnancy subtherapeutic exposure may occur, leaving a whole new generation at risk for infection with HIV and transmission of drug resistance. Therefore, it was investigated what dosing regimen was most likely to result in therapeutic exposure. It was found that a twice-daily dose of 600 mg, in combination with ritonavir (100 mg) was the best dose during pregnancy.
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling.
Schalkwijk S, Ter Heine R, Colbers A, Capparelli E, Best BM, Cressey TR, Greupink R, Russel FGM, Moltó J, Mirochnick M, Karlsson MO, Burger DM.
Stein Schalkwijk, Rob ter Heine, Angela Colbers and David Burger are all members of theme Infectious diseases and global health.
Related news items
Guiding the surgeon real-time tumor visualization during surgery26 February 2020
Incomplete excision of tumor tissue, negatively affects the prognosis of the patient. Mark Rijpkema and colleagues are working on the development of new dual-labeled tracers and currently are implementing this into the clinic.read more
Jurgen Fütterer appointed Professor of Image-Guided Oncological Interventions26 February 2020
Fütterer is an interventional radiologist and is also Professor at the Robotics and Mechatronics Group at the University of Twente. The new professor is an expert in the field of cancer imaging techniques, image-guided interventions and robotics.read more
Arnt Schellekens appointed Professor of Addicition and Psychiatry26 February 2020
Arnt Schellekens has been appointed professor of Addiction and Psychiatry at Radboud University / Radboud university medical center with effect from 1 January 2020.read more
NWO GROOT grant for Michiel Vermeulen24 February 2020
Michiel Vermeulen, theme Cancer development and immune defense, received a 300,000 EUR grant within the NWO-GROOT consortium. He will use mass spectrometry-based proteomics and interaction proteomics applications to study proteome and gene expression dynamics during early C. Elegans development.read more